Floatz logo

2-PROPEN-1-ONE, 1-(2-FLUOROPHENYL)-3-(4-HYDROXYPHENYL)-, O-(2-(DIMETHYLAMINO)ETHYL)OXIME, (1Z,2E)-

Sleep

SanofiSmall moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
89/ 100

Competitive context

15 Active assets in the Sleep cohort.

Asset / SponsorPhaseRating
Trazodone
Johns Hopkins University
Phase 4BB
Armodafinil
Cephalon
Phase 4BB
Tvp-1012
Technische Universität Dresden
Phase 4BB
MELATONIN
Duke University
Phase 3BB
Olanzapine
Central Institute of Psychiatry, Ranchi, India
Phase 4BB

View all 36 →

Same molecule, other indications

2-PROPEN-1-ONE, 1-(2-FLUOROPHENYL)-3-(4-HYDROXYPHENYL)-, O-(2-(DIMETHYLAMINO)ETHYL)OXIME, (1Z,2E)- is also rated in:

fibromyalgiaDormant
B
Indicative ·
57 / 100
View asset →
chronic pain syndromeDormant
CCC
Indicative ·
54 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →